Stefan Scherer

Person

South San Francisco, CA, US

People

Patents Applicationslast 30 patents

Information Patent Application
BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR T...
- Publication number 20140302019
- Publication date Oct 9, 2014
- Hoffmann-La Roche Inc.
- Paul DELMAR
- G01 - MEASURING TESTING
Information Patent Application
Method to identify a patient with an increased likelihood of respon...
- Publication number 20130344060
- Publication date Dec 26, 2013
- Hoffmann-La Roche Inc.
- Herbert Andres
- G01 - MEASURING TESTING
Information Patent Application
METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPON...
- Publication number 20130243758
- Publication date Sep 19, 2013
- Hoffmann-La Roche Inc.
- HERBERT ANDRES
- G01 - MEASURING TESTING
Information Patent Application
BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR T...
- Publication number 20130195857
- Publication date Aug 1, 2013
- Hoffmann-La Roche Inc.
- Paul DELMAR
- G01 - MEASURING TESTING
Information Patent Application
BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR T...
- Publication number 20130183301
- Publication date Jul 18, 2013
- Hoffmann-La Roche Inc.
- Paul DELMAR
- G01 - MEASURING TESTING
Information Patent Application
NEUROPILIN AS A BIOMARKER FOR BEVACIZUMAB COMBINATION THERAPIES
- Publication number 20130183304
- Publication date Jul 18, 2013
- Hoffmann-La Roche Inc.
- Paul DELMAR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR T...
- Publication number 20130183302
- Publication date Jul 18, 2013
- HOFFMAN-LA ROCHE INC.
- Sanne Lysbet DE HAAS
- G01 - MEASURING TESTING
Information Patent Application
BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR T...
- Publication number 20130183303
- Publication date Jul 18, 2013
- HOFFMAN-LA ROCHE INC.
- Sanne Lysbet DE HAAS
- G01 - MEASURING TESTING
Information Patent Application
METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPON...
- Publication number 20130183300
- Publication date Jul 18, 2013
- Hoffmann-La Roche Inc.
- HERBERT ANDRES
- G01 - MEASURING TESTING
Information Patent Application
NEUROPILIN AS A BIOMARKER FOR BEVACIZUMAB COMBINATION THERAPIES
- Publication number 20130177554
- Publication date Jul 11, 2013
- Hoffmann-La Roche Inc.
- Paul DELMAR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPON...
- Publication number 20130171135
- Publication date Jul 4, 2013
- F. Hoffmann-La Roche AG
- Herbert ANDRES
- G01 - MEASURING TESTING
Information Patent Application
NEUROPILIN AS A BIOMARKER FOR BEVACIZUMAB COMBINATION THERAPIES
- Publication number 20130171134
- Publication date Jul 4, 2013
- F. Hoffmann-La Roche AG
- Paul DELMAR
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR T...
- Publication number 20130121999
- Publication date May 16, 2013
- F. Hoffmann-La Roche AG
- Sanne Lysbet DE HAAS
- G01 - MEASURING TESTING
Information Patent Application
BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR T...
- Publication number 20130108626
- Publication date May 2, 2013
- F. Hoffmann-La Roche AG
- Paul DELMAR
- G01 - MEASURING TESTING
Information Patent Application
Methods to identify responsive patients
- Publication number 20110182892
- Publication date Jul 28, 2011
- HOFFMAN-LA ROCHE INC.
- Paul Delmar
- G01 - MEASURING TESTING
Information Patent Application
METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS
- Publication number 20110064732
- Publication date Mar 17, 2011
- Sanne Lysbet De Haas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Stefan Scherer

Person

Patents Applicationslast 30 patents

BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR T...

Method to identify a patient with an increased likelihood of respon...

METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPON...

BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR T...

BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR T...

NEUROPILIN AS A BIOMARKER FOR BEVACIZUMAB COMBINATION THERAPIES

BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR T...

BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR T...

METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPON...

NEUROPILIN AS A BIOMARKER FOR BEVACIZUMAB COMBINATION THERAPIES

METHOD TO IDENTIFY A PATIENT WITH AN INCREASED LIKELIHOOD OF RESPON...

NEUROPILIN AS A BIOMARKER FOR BEVACIZUMAB COMBINATION THERAPIES

BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR T...

BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR T...

Methods to identify responsive patients

METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS